Daclatasvir API is a direct-acting antiviral agent used in the treatment of chronic hepatitis C virus (HCV) infection. It inhibits the NS5A protein and is suitable for oral solid dosage formulations.

Daclatasvir API is manufactured and supplied by Artis Biotech | ASTANDARDS, ensuring high purity, consistent quality, and regulatory-compliant specifications. Our APIs are produced using validated processes and are suitable for research, development, and pharmaceutical manufacturing applications.